FilingReader Intelligence
Cohance provides $16.5m guarantee for US subsidiary facility
July 29, 2025 at 03:10 PM UTC•By FilingReader AI
Cohance Lifesciences Limited issued a corporate guarantee of up to $16.5 million to Citibank for a credit facility of up to $15 million for its subsidiary, NJ Bio Inc.
The guarantee supports NJ Bio Inc.'s bioconjugation requirements in the U.S. and is valid until June 30, 2028.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
BSE:SUVENPHAR•Bombay Stock Exchange
News Alerts
Get instant email alerts when SUVEN PHARMACEUTICALS publishes news
Free account required • Unsubscribe anytime